<DOC>
	<DOCNO>NCT00070850</DOCNO>
	<brief_summary>Smith-Lemli-Opitz Syndrome ( SLOS ) genetic condition cause mental retardation birth defect . This study evaluate new prenatal screen test SLOS .</brief_summary>
	<brief_title>Prenatal Screening For Smith-Lemli-Opitz Syndrome</brief_title>
	<detailed_description>SLOS inherit metabolic disorder characterize moderate severe mental retardation congenital anomaly . SLOS cause deficiency enzyme 7-dehydrocholesterol reductase result defect conversion 7-dehydrocholesterol cholesterol . SLOS reliably detect prenatally analysis amniotic fluid 7-8- dehydrocholesterol ( 7/8-DHC ) level . Unconjugated estriol ( uE3 ) one maternal serum analytes currently measure routinely screen Down syndrome . This analyte require cholesterol precursor , concentration maternal serum lower fetus SLOS . Currently , national standard approach take prenatal screening ; exist program vary availability protocol algorithm use . The major barrier identify SLOS prenatally absence sound screen methodology take account detection rate , false positive rate , prevalence . This study evaluate efficacy routinely identify Smith-Lemli-Opitz Syndrome ( SLOS ) prenatally . The screen model study base data SLOS pregnancy test 1,000,000 pregnancy maternal serum uE3 , alpha-fetoprotein , human chorionic gonadotrophin measurement do part routine screen Down syndrome . The screening false positive rate project 0.34 % , detection rate 62 % , odds affect give positive screen result 1:70 . These rate compare favorably prenatal screening test routine use . The study also determine whether SLOS diagnostic study carry maternal urine serum , rather amniotic fluid , thereby avoid invasive procedure . Participants study pregnant woman undergo amnioscentisis second trimester . Women positive test SLOS ask provide urine blood sample . The study collect data patient demographic family history ; data also obtain participant ’ ultrasound , karyotype , alpha-fetoprotein , maternal serum screening , SLOS report . Three month pregnancy due date , genetic counselor contact participant obtain basic information baby ’ delivery health .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<criteria>Inclusion Criteria Pregnant , second trimester Singleton pregnancy Positive second trimester maternal serum screen SmithLemliOpitz Syndrome ( use Foundation Blood Research screen algorithm ) Exclusion criterion : Gestational age time serum collection outside range accept Down Syndrome screen Not pregnant Twin/multiple pregnancy Sample/clerical/assay error Physician participating study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Screening</keyword>
	<keyword>Prenatal</keyword>
	<keyword>Amniocentesis</keyword>
</DOC>